EP.110Clinical and neurophysiological outcome of a patient with predicted type 1 SMA presymptomatically treated with nusinersen

Autor: Alvarez Molinero, M., Gómez-Andrés, D., Gratacós Viñola, M., Toro Tamargo, E., Costa Comellas, L., Gonzalez Gardó, L., Iglesias, I., Macaya, A., Munell, F.
Zdroj: In Neuromuscular Disorders October 2019 29 Supplement 1:S200-S200
Databáze: ScienceDirect